Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Mengo 3DPol Inhibitors

Mengo 3DPol inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of the 3D polymerase (3DPol) enzyme of the Mengovirus, a member of the Picornaviridae family. The 3DPol enzyme is an RNA-dependent RNA polymerase (RdRp) responsible for the replication of the viral RNA genome. This enzyme plays a crucial role in the viral life cycle by catalyzing the synthesis of new RNA strands from the viral RNA template, a process essential for the production of progeny virions. By inhibiting 3DPol, researchers can effectively block the replication of the viral genome, providing a powerful tool to study the molecular mechanisms of RNA synthesis in Mengovirus and other related viruses.

In research, Mengo 3DPol inhibitors are invaluable for dissecting the replication machinery of picornaviruses and understanding the specific contributions of the 3D polymerase to viral RNA synthesis. By blocking the activity of 3DPol, scientists can investigate how the inhibition affects viral replication, including the dynamics of RNA synthesis, the formation of replication complexes, and the overall efficiency of viral genome production. These inhibitors also allow researchers to explore the structural and functional aspects of the 3D polymerase, including its interactions with other viral and host proteins that are critical for the replication process. Additionally, Mengo 3DPol inhibitors provide insights into the broader mechanisms of RNA virus replication, helping to elucidate the conserved features and unique aspects of RdRp function across different viruses within the Picornaviridae family. Through these studies, the use of Mengo 3DPol inhibitors contributes to a deeper understanding of viral replication mechanisms, the role of RNA polymerases in the viral life cycle, and the potential vulnerabilities in the replication process that could be exploited for broader virological research.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Sofosbuvir

1190307-88-0sc-482362
25 mg
$146.00
1
(0)

Sofosbuvir is a well-known RdRp inhibitor, potentially affecting Mengo 3DPol by inhibiting the polymerase activity.

Ribavirin

36791-04-5sc-203238
sc-203238A
sc-203238B
10 mg
100 mg
5 g
$63.00
$110.00
$214.00
1
(1)

Ribavirin, a broad-spectrum antiviral, may inhibit Mengo 3DPol indirectly through its RdRp inhibitory action.

Leflunomide

75706-12-6sc-202209
sc-202209A
10 mg
50 mg
$20.00
$83.00
5
(1)

Leflunomide, an immunosuppressive drug, has been suggested to inhibit viral RdRp, potentially affecting Mengo 3DPol.

Tenofovir

147127-20-6sc-204335
sc-204335A
10 mg
50 mg
$157.00
$646.00
11
(1)

Tenofovir, primarily used in HIV and Hepatitis B, might influence RdRp and indirectly affect Mengo 3DPol.